Tabletting medicine auxiliary material, tablet and preparation method of tablet

Through the mechanical mixing of carboxylated cellulose nanocrystals and microcrystalline cellulose, the problem of poor cellulose nanocrystals is solved, the fluidity and disintegration speed of pharmaceutical excipients are improved, and the compressibility of the tablet is ensured. and drug loading rate, suitable for commercial production.

CN118903443APending Publication Date: 2024-11-08ZHEJIANG SCI-TECH UNIV +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410907144.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-08
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Due to its high specific surface area and nano-size characteristics, cellulose nanocrystals increase and aggregation, resulting in less easy flow in dry powder state, affecting its application as a tablet pharmaceutical auxiliary material, especially when it is quickly pressed. There are problems of uneven quality and inconsistent hardness of tablets.

Method used

Carboxylated cellulose nanocrystals are used to mechanically mix carboxylated cellulose nanocrystals and microcrystalline cellulose to prepare carboxylated cellulose nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline nanocrystalline Disintegration performance.

Benefits of technology

The fluidity and disintegration rate of pharmaceutical excipients are improved, the compressibility and drug loading rate of the tablet are ensured, and the poor fluidity of cellulose nanocrystals is solved, while the high drug loading rate and rapid disintegration are ensured. Features are suitable for commercial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903443A_ABST
    Figure CN118903443A_ABST
Patent Text Reader

Abstract

The invention relates to a medicine auxiliary material for tabletting, a tablet and a preparation method thereof, the medicine auxiliary material for tabletting comprises microcrystalline cellulose and carboxylated cellulose nanocrystal, and the mass ratio of the carboxylated cellulose nanocrystal to the microcrystalline cellulose is 1: (1.5-2.5); the preparation method of the tablet comprises the following steps: uniformly mixing the carboxylated cellulose nanocrystal and the microcrystalline cellulose in the medicinal auxiliary material for tabletting; uniformly mixing the uniformly mixed pharmaceutical excipients with the active pharmaceutical ingredients, and then tabletting in a tablet press to obtain tablets; wherein the mass ratio of the pharmaceutic adjuvants to the active pharmaceutical ingredients is 2: 1. The pharmaceutic adjuvant disclosed by the invention has excellent flowability, and the prepared tablet has ultrafast disintegration property, good compressibility and ultrahigh drug loading rate; the pharmaceutic adjuvant can be widely applied to various oral solid preparations, and is particularly suitable for preparing various tablets by a direct tabletting method.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of pharmaceutical tablets, and in particular relates to a pharmaceutical excipient for tableting, a tablet and a preparation method thereof. Background Art

[0002] Pharmaceutical excipients are a general term for all substances added to drug formulations in addition to active ingredients. These excipients play a vital role in the pharmaceutical industry, including improving the formation, effect, stability and safety of drugs. Pharmaceutical excipients not only provide specific dosage forms for drugs, but also help to enhance drug efficacy and reduce side effects. Their quality and diversity are key to ensuring the advancement and efficiency of drug preparations. Excipients play an indispensable role in the preparation and development of drugs.

[0003] Tablets are a common solid drug dosage form, mainly administered orally. They are small flat round or polygonal shapes compressed from the active pharmaceutical ingredient API and one or more pharmaceutical excipients. They are widely used because of their ease of production, transportation, storage and precise dosage, and are one of the most common dosage forms for oral administration. The main preparation processes for tablets are direct compression, wet granulation and dry granulation. Among them, direct compression is the simplest to operate, with high efficiency, low cost and good drug stability, and has the greatest industrial prospects. The direct compression method has very high requirements for pharmaceutical excipients. The excipients must not only have good fluidity and compressibility, but also good formability, which is especially important for some APIs that are difficult to compress.

[0004] Cellulose nanocrystals (CNCs) have attracted widespread attention in the pharmaceutical field due to their unique nanosize, high specific surface area, and excellent mechanical properties. As a highly biodegradable and non-toxic natural polymer material, CNCs can be used to develop new drug delivery systems, especially showing great potential in improving drug bioavailability and achieving directional release. In addition, due to the abundant hydroxyl groups on the surface of CNCs, they can optimize the interaction with drug molecules through specific surface modification, thereby enhancing the efficiency and specificity of drug carriers. In summary, cellulose nanocrystals are also a potential high-end pharmaceutical excipient that can be directly compressed into tablets.

[0005] However, due to its high specific surface area and nano-size characteristics, CNCs particles tend to form a stable network structure through hydrogen bonding interactions, resulting in increased friction between particles and difficulty in free flow in the dry powder state. In addition, the high surface energy of CNCs particles also makes them prone to aggregation, further reducing fluidity. Therefore, if CNCs are directly used as pharmaceutical excipients for tablets for rapid tableting, problems such as uneven tablet quality and inconsistent hardness will occur under rapid tableting, seriously affecting its application in commercial pharmaceuticals. Wet granulation and the addition of flow improvers such as silicon dioxide and talc are common methods to improve the flow of pharmaceutical excipients, but the water or solvent introduced by wet granulation may affect the stability of the drug ingredients, and the addition of flow improvers may affect the purity and quality of the tablets.

[0006] Therefore, how to effectively improve the fluidity of cellulose nanocrystals without affecting their inherent properties is a difficult problem that needs to be solved urgently in this field. Summary of the invention

[0007] Based on the above-mentioned deficiencies in the prior art, the object of the present invention is to provide a pharmaceutical excipient for tableting with ultra-fast disintegration and high drug loading rate, a tablet and a preparation method thereof.

[0008] In order to achieve the above-mentioned object of the invention, the present invention adopts the following technical solutions:

[0009] A pharmaceutical excipient for tableting comprises microcrystalline cellulose and carboxylated cellulose nanocrystals, wherein the mass ratio of the carboxylated cellulose nanocrystals to the microcrystalline cellulose is 1:(1.5-2.5).

[0010] As a preferred embodiment, the preparation process of the carboxylated cellulose nanocrystals includes:

[0011] Adding microcrystalline cellulose to the aqueous solution of L-malic acid and stirring thoroughly to obtain a mixed solution;

[0012] The mixed solution is placed in a water bath at a target temperature for esterification and hydrolysis, and then centrifuged, washed, and freeze-dried to obtain carboxylated cellulose nanocrystals.

[0013] As a preferred embodiment, the mass ratio of the microcrystalline cellulose to L-malic acid is 1:(16-20).

[0014] As a preferred embodiment, the mass ratio of L-malic acid to water in the aqueous solution of L-malic acid is 1:(1-2).

[0015] As a preferred solution, the target temperature is 92-98° C. and the esterification hydrolysis time is 3-5 hours.

[0016] The present invention also provides a method for preparing a tablet, comprising:

[0017] Mixing the carboxylated cellulose nanocrystals and microcrystalline cellulose in the pharmaceutical excipient for tableting as described in any of the above schemes uniformly;

[0018] The mixed pharmaceutical excipients are mixed evenly with the active pharmaceutical ingredient, and then compressed in a tablet press to obtain tablets;

[0019] Among them, the mass ratio of pharmaceutical excipients to pharmaceutical active ingredients is 2:1.

[0020] As a preferred solution, the tabletting pressure is 10 to 20 kN and the tabletting speed is 60 to 180 tablets / min.

[0021] As a preferred embodiment, the active ingredient of the medicine is tetracycline hydrochloride, oxytetracycline hydrochloride, aspirin or Scutellaria baicalensis leaves.

[0022] The present invention also provides tablets prepared by the preparation method described in any of the above schemes.

[0023] As a preferred solution, the disintegration time of the tablet does not exceed 5 seconds, and the drug loading rate is not less than 85%.

[0024] Compared with the prior art, the present invention has the following technical effects:

[0025] (1) The main components of the pharmaceutical excipient of the present invention are carboxylated cellulose nanocrystals and microcrystalline cellulose. Microcrystalline cellulose is an excellent pharmaceutical excipient with excellent compressibility and fluidity. It is currently the most widely used excipient for direct powder tableting and belongs to the same cellulose pharmaceutical excipient as carboxylated cellulose nanocrystals. The two are mechanically mixed to improve the fluidity of carboxylated cellulose nanocrystals and obtain a mixed pharmaceutical excipient with fast disintegration speed, improved drug loading rate and improved compressibility.

[0026] (2) The pharmaceutical excipient of the present invention is a mechanical mixture of carboxylated cellulose nanocrystals and microcrystalline cellulose, and the preparation process is simple and fast;

[0027] (3) The pharmaceutical excipient of the present invention can be directly mixed with the main drug and compressed into tablets as a premixed excipient. Through a simple mechanical blending method, the problem that the commercial development of cellulose nanocrystals as a new high-end and promising excipient that can be directly compressed into tablets is limited due to poor fluidity is successfully solved; while improving the fluidity of carboxylated cellulose nanocrystals, it also ensures that the excipient has the characteristics of high drug loading rate, ultrafast disintegration, good compressibility and non-fragility. The preparation method of the tablet of the present invention is simple, easy to operate, easy to mass produce, has a large market demand, and has a wide range of practical value. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 This is a SEM image of the carboxylated cellulose nanocrystals of Example 1 of the present invention;

[0029] Figure 2 The infrared test graphs of the pharmaceutical excipients of the embodiments of the present invention and the pharmaceutical excipients of microcrystalline cellulose of the comparative example;

[0030] Figure 3 This is a SEM image of the tablet of Example 1 of the present invention;

[0031] Figure 4 This is a schematic diagram of the disintegration process of the tablet of Example 1 of the present invention;

[0032] Figure 5 This is a schematic diagram of the disintegration process of the tablet of Comparative Example 1 of the present invention;

[0033] Figure 6 Schematic diagram of the disintegration process of the tablet of Comparative Example 3 of the present invention. DETAILED DESCRIPTION

[0034] The technical solution of the present invention is further explained below through specific embodiments.

[0035] Embodiment 1:

[0036] (1) Preparation of carboxylated cellulose nanocrystals CNC: solid L-malic acid is added to microcrystalline cellulose, the mass of L-malic acid is 18 times the mass of microcrystalline cellulose; an appropriate amount of deionized water is added thereto (the volume of deionized water is numerically equal to the mass of L-malic acid); the mixed solution is placed in a 98°C water bath and stirred (at a speed of 450 r / min) for 5 h; after sufficient reaction, it is cooled to room temperature and diluted with deionized water; centrifugation is then performed, the supernatant is removed, and the operation is repeated until the pH value of the upper liquid is 7; and freeze-drying is performed to obtain carboxylated cellulose nanocrystals;

[0037] (2) Take an appropriate amount of carboxylated cellulose nanocrystals and microcrystalline cellulose (mass ratio is 1:2), place them in a stainless steel basin, and stir them continuously with a polytetrafluoroethylene paddle until they are evenly mixed;

[0038] (3) Take an appropriate amount of the above-mentioned mixed excipients and tetracycline hydrochloride (mass ratio 2:1), place them in a stainless steel basin, and stir them continuously with a polytetrafluoroethylene paddle until they are uniformly mixed; place the uniform powder on a tablet press and press it quickly (180 tablets / / min) at a pressure of 15KN to obtain tetracycline hydrochloride tablets.

[0039] like Figure 1 As shown, the carboxylated cellulose nanocrystals prepared in this example are rod-shaped and about 200 nanometers in length. The rod-shaped morphology brings high specific surface area and high surface energy, which increases the drug loading rate while also increasing the attraction and friction between the cellulose nanocrystals, resulting in poor fluidity.

[0040] like Figure 2As shown in the figure, compared with the raw microcrystalline cellulose, the carboxylated cellulose nanocrystals have a -1 A new carbonyl peak appeared at , proving the successful introduction of carboxyl groups. It is precisely because of the introduction of carboxyl groups that carboxylated cellulose nanocrystals have good hydrophilicity and accelerate the disintegration of tablets.

[0041] like Figure 3 As shown, it can be seen that the tablets of Example 1 are uniform in size, smooth in surface and perfect in shape, and can be adapted to industrial production.

[0042] Embodiment 2:

[0043] (1) Preparation of carboxylated cellulose nanocrystals CNC: solid L-malic acid is added to microcrystalline cellulose, the mass of L-malic acid is about 18 times the mass of microcrystalline cellulose; an appropriate amount of deionized water (the volume of the deionized water is numerically equal to the mass of the L-malic acid) is added thereto; the mixed solution is placed in a 98°C water bath and stirred (at a speed of 450 r / min) for 5 h; after sufficient reaction, it is cooled to room temperature and diluted with deionized water; centrifugation is then performed, the supernatant is removed, and the operation is repeated until the pH value of the upper liquid is 7; and freeze-drying is performed to obtain carboxylated cellulose nanocrystals;

[0044] (2) Take an appropriate amount of carboxylated cellulose nanocrystals and microcrystalline cellulose (mass ratio is 1:2), place them in a stainless steel basin, and stir them continuously with a polytetrafluoroethylene paddle until they are evenly mixed;

[0045] (3) Take an appropriate amount (mass ratio of 2:1) of the above-mentioned mixed auxiliary materials and Scutellaria baicalensis leaves (which have been crushed into fine powder), place them in a stainless steel basin, and stir them continuously with a polytetrafluoroethylene paddle until the mixture is uniform; place the uniform powder on a tablet press and press it quickly (180 tablets / min) at a pressure of 15 kN to obtain Scutellaria baicalensis tablets.

[0046] Comparative Example 1:

[0047] Take an appropriate amount of carboxylated cellulose nanocrystals and tetracycline hydrochloride (mass ratio 2:1) as in Example 1, place them in a stainless steel basin, and stir them continuously with a polytetrafluoroethylene stirring paddle until they are uniformly mixed; place the uniform powder on a tablet press and press it quickly (180 tablets / min) at a pressure of 15 kN to obtain tetracycline hydrochloride tablets.

[0048] Comparative Example 2:

[0049] Take appropriate amounts of carboxylated cellulose nanocrystals and Scutellaria baicalensis leaves (crushed into powder) as in Example 1 (mass ratio 2:1), place them in a stainless steel basin, and stir continuously with a polytetrafluoroethylene stirring paddle until the mixture is uniform; place the uniform powder on a tablet press and press quickly (180 tablets / min) at a pressure of 15 kN to obtain Scutellaria baicalensis tablets.

[0050] Comparative Example 3:

[0051] Take appropriate amounts of microcrystalline cellulose and tetracycline hydrochloride (mass ratio 2:1) as in Example 1, place them in a stainless steel basin, and stir them continuously with a polytetrafluoroethylene stirring paddle until they are uniformly mixed; place the uniform powder on a tablet press and press it quickly (180 tablets / min) at a pressure of 15 kN to obtain tetracycline hydrochloride tablets.

[0052] Comparative Example 4:

[0053] Take appropriate amounts of microcrystalline cellulose and Scutellaria baicalensis leaves (crushed into powder) as in Example 1 (mass ratio 2:1), place them in a stainless steel basin, and stir continuously with a polytetrafluoroethylene stirring paddle until the mixture is uniform; place the uniform powder on a tablet press and press quickly (180 tablets / min) at a pressure of 15 kN to obtain Scutellaria baicalensis tablets.

[0054] Comparative Example 5:

[0055] (1) mixing the carboxylated cellulose nanocrystals and microcrystalline cellulose prepared in Example 1 in a mass ratio of 2:1;

[0056] (2) Take an appropriate amount of the above-mentioned mixed excipients and tetracycline hydrochloride (mass ratio 2:1), place them in a stainless steel basin, and stir them continuously with a polytetrafluoroethylene stirring paddle until the mixture is uniform; place the uniform powder on a tablet press and press it quickly (180 tablets / min) at a pressure of 15 kN to obtain tetracycline hydrochloride tablets.

[0057] Comparative Example 6:

[0058] (1) mixing carboxylated cellulose nanocrystals and microcrystalline cellulose of the same example in a mass ratio of 2:1;

[0059] (2) Take an appropriate amount (mass ratio of 2:1) of the above-mentioned mixed auxiliary materials and Scutellaria baicalensis leaves (which have been crushed into fine powder), place them in a stainless steel basin, and stir them continuously with a polytetrafluoroethylene stirring paddle until the mixture is uniform; place the uniform powder on a tablet press and press it quickly (180 tablets / min) at a pressure of 1 kKN to obtain Scutellaria baicalensis tablets.

[0060] Comparative Example 7:

[0061] (1) mixing the carboxylated cellulose nanocrystals and microcrystalline cellulose prepared in Example 1 in a mass ratio of 1:1;

[0062] (2) Take an appropriate amount of the above-mentioned mixed excipients and tetracycline hydrochloride (mass ratio 2:1), place them in a stainless steel basin, and stir them continuously with a polytetrafluoroethylene stirring paddle until the mixture is uniform; place the uniform powder on a tablet press and press it quickly (180 tablets / min) at a pressure of 15 kN to obtain tetracycline hydrochloride tablets.

[0063] Comparative Example 8:

[0064] (1) mixing the carboxylated cellulose nanocrystals and microcrystalline cellulose prepared in Example 1 in a mass ratio of 1:1;

[0065] (2) Take an appropriate amount (mass ratio of 2:1) of the above-mentioned mixed auxiliary materials and Scutellaria baicalensis leaves (which have been crushed into fine powder), place them in a stainless steel basin, and stir them continuously with a polytetrafluoroethylene stirring paddle until the mixture is uniform; place the uniform powder on a tablet press and press it quickly (180 tablets / min) at a pressure of 15 kN to obtain Scutellaria baicalensis tablets.

[0066] Comparative Example 9:

[0067] (1) mixing the carboxylated cellulose nanocrystals and microcrystalline cellulose prepared in Example 1 in a mass ratio of 1:3;

[0068] (2) Take an appropriate amount of the above-mentioned mixed excipients and tetracycline hydrochloride (mass ratio 2:1), place them in a stainless steel basin, and stir them continuously with a polytetrafluoroethylene stirring paddle until the mixture is uniform; place the uniform powder on a tablet press and press it quickly (180 tablets / min) at a pressure of 15KN to obtain tetracycline hydrochloride tablets.

[0069] Comparative Example 10:

[0070] (1) mixing carboxylated cellulose nanocrystals with microcrystalline cellulose in a mass ratio of 1:3;

[0071] (2) Take an appropriate amount (mass ratio of 2:1) of the above-mentioned mixed auxiliary materials and Scutellaria baicalensis leaves (which have been crushed into fine powder), place them in a stainless steel basin, and stir them continuously with a polytetrafluoroethylene stirring paddle until the mixture is uniform; place the uniform powder on a tablet press and press it quickly (180 tablets / min) at a pressure of 15 kN to obtain Scutellaria baicalensis tablets.

[0072] The tablets obtained in the above examples and comparative examples were tested as follows:

[0073] 1. Disintegration time: Since the tablets of Examples 1 and 2 disintegrate very quickly, their disintegration performance cannot be effectively tested using a dynamic disintegrator. Therefore, the static natural disintegration method was used to characterize their disintegration performance. The tablets were placed in a glass bottle containing 10 mL of deionized water, and the time was counted from the time the tablet entered the water until it began to disintegrate into small pieces;

[0074] 2. Drug loading rate: First, place the tablets in 50 mL of dilute hydrochloric acid solution and stir at 200 rpm for 6 hours; after stirring, take a sample from the middle of the solution and dilute it by a certain multiple; then use a UV-visible spectrophotometer to measure the absorption peak intensity of the solution; by comparing with the standard absorbance curve of the active ingredient of the drug, calculate the actual drug loading in the tablet; the drug loading rate is obtained by dividing the measured drug loading by the theoretical drug loading.

[0075] The test results obtained are shown in Table 1 and Table 2. The pharmaceutical excipients and tablets of the embodiments of the present invention have the following characteristics:

[0076] 1. Good powder fluidity: specifically, the repose angle is less than 30 degrees, and smaller than other control groups;

[0077] 2. The disintegration time is within 5s, the disintegration speed is excellent and is smaller than other control groups;

[0078] 3. The tablets have good physical strength and are not easy to break;

[0079] 4. The drug loading rate is significantly higher than that of microcrystalline cellulose, approaching that of carboxylated cellulose nanocrystals;

[0080] Table 1 Performance parameters of the tablets of Example 1-2

[0081]

[0082] In contrast, pure carboxylated cellulose nanocrystals, pure microcrystalline cellulose and mixtures in other proportions cannot meet the above performance requirements, or cannot simultaneously meet the requirements of good fluidity, short disintegration time, good compressibility, non-breakability and high drug loading rate.

[0083] Table 2 Performance parameters of comparative examples 1-10 tablets

[0084]

[0085] like Figure 4 As shown, the tablets prepared in Example 1 exhibit excellent rapid disintegration performance. The tablets began to disintegrate rapidly within 3 seconds after contacting water, and at the 10th second, their disintegration state was basically the same as at 3 seconds, indicating that the tablets had reached a state of nearly complete disintegration. This rapid disintegration behavior can be attributed to the effective synergistic effect between the good swelling properties of microcrystalline cellulose and the excellent hydrophilicity of carboxylated cellulose nanocrystals. MCC rapidly absorbs water and swells in water, while CNC enhances its interaction with water due to its high specific surface area and surface carboxylation modification, thereby significantly accelerating water penetration and the overall disintegration process. This unique physical and chemical synergistic effect gives the tablets significant advantages in rapid drug release, making them an ideal choice for use in pharmaceutical formulations that require immediate release of active ingredients.

[0086] like Figure 5 As shown in the figure, the tablet prepared in Comparative Example 1 exhibited excellent disintegration performance, and it had disintegrated at 7 seconds. However, despite the fast disintegration speed, it can be clearly observed that the disintegration degree was relatively general. This shows that although the carboxylated cellulose nanocrystals have good hydrophilicity and promote rapid water absorption, their swelling property is relatively weak.

[0087] like Figure 6As shown, the tablets prepared in Comparative Example 3 have average disintegration properties. At 30 seconds, it can be observed that compared with the initial contact with water, the tablet volume is significantly increased, but no fine fragments are produced when the tablet disintegrates; and the swelling effect of the center of the tablet is poorer than that of the edge. This is because the pressure in the center of the tablet is greater than the pressure at the edge during tablet compression, which is also related to the general water conductivity of microcrystalline cellulose. In addition, due to its large particles, it is not easy to disintegrate and disperse in water, affecting the drug release.

[0088] The disintegration time of all tablets in the comparative examples is shorter than that of the examples. This is due to the cooperation between carboxylated cellulose nanocrystals and microcrystalline cellulose. Microcrystalline cellulose has a low degree of crystallinity and has more amorphous regions, which causes it to swell rapidly when in contact with water. The carboxylated cellulose nanocrystals, due to their unique rod-like structure, accelerate the rapid conduction of water molecules in the tablets and accelerate their disintegration. At the same time, the fluidity of the comparative examples is also shorter than that of the examples. This is because the carboxylated cellulose nanocrystals can adhere to the surface of microcrystalline cellulose due to their large specific surface area and surface energy, so that the particle size of both the carboxylated cellulose nanocrystals and the microcrystalline cellulose has changed to a certain extent, thereby improving the fluidity of the auxiliary materials.

[0089] Compared with the drug loading rate of carboxylated cellulose nanocrystals alone, the drug loading rate of the embodiment did not change significantly due to the correct ratio, although microcrystalline cellulose was introduced.

[0090] In the above embodiment and its alternatives, the mass ratio of carboxylated cellulose nanocrystals to microcrystalline cellulose can also be 1:1.5, 1:1.8, 1:2.2, 1:2.4, 1:2.5, etc.

[0091] In the above embodiment and its alternatives, the mass ratio of microcrystalline cellulose to L-malic acid can also be 1:16, 1:17, 1:19, 1:20, etc.

[0092] In the above embodiment and its alternatives, the mass ratio of L-malic acid to water in the aqueous solution of L-malic acid can also be 1:1.2, 1:1.4, 1:1.5, 1:2, etc.

[0093] In the above embodiment and its alternatives, the target temperature of esterification can also be 92°C, 94°C, 95°C, 96°C, 97°C, etc., and the esterification hydrolysis time can also be 3h, 3.5h, 4h, 4.5h, etc.

[0094] In the above embodiments and their alternatives, the tableting pressure can also be 10kN, 12kN, 14kN, 16kN, 18kN, 20kN, etc., and the speed can also be 60 tablets / min, 80 tablets / min, 100 tablets / min, 120 tablets / min, 150 tablets / min, 160 tablets / min, 170 tablets / min, etc.

[0095] In view of the numerous embodiments of the scheme of the present invention, the raw materials and dosage involved can be selected according to actual needs within the limited range, and the experimental data of each embodiment is huge and numerous, which is not suitable for listing and explaining one by one here, but the content required to be verified and the final conclusion obtained in each embodiment are similar. Therefore, the verification content of each embodiment will not be explained one by one here.

[0096] The above description is only a detailed description of the preferred embodiments and principles of the present invention. For ordinary technicians in this field, according to the ideas provided by the present invention, there will be changes in the specific implementation methods, and these changes should also be regarded as the protection scope of the present invention.

Claims

1. A pharmaceutical excipient for tableting, characterized in that: It comprises microcrystalline cellulose and carboxylated cellulose nanocrystals, and the mass ratio of the carboxylated cellulose nanocrystals to the microcrystalline cellulose is 1:(1.5-2.5).

2. The pharmaceutical excipient for tableting according to claim 1, characterized in that: The preparation process of the carboxylated cellulose nanocrystals comprises: Adding microcrystalline cellulose to the aqueous solution of L-malic acid and stirring thoroughly to obtain a mixed solution; The mixed solution is placed in a water bath at a target temperature for esterification and hydrolysis, and then centrifuged, washed, and freeze-dried to obtain carboxylated cellulose nanocrystals.

3. The pharmaceutical excipient for tableting according to claim 2, characterized in that: The mass ratio of the microcrystalline cellulose to L-malic acid is 1:(16-20).

4. The pharmaceutical excipient for tableting according to claim 2, characterized in that: The mass ratio of L-malic acid to water in the aqueous solution of L-malic acid is 1:(1-2).

5. The pharmaceutical excipient for tableting according to claim 2, characterized in that: The target temperature is 92-98° C. and the esterification hydrolysis time is 3-5 hours.

6. A method for preparing a tablet, characterized in that: include: Mixing the carboxylated cellulose nanocrystals and microcrystalline cellulose in the pharmaceutical excipient for tableting as claimed in any one of claims 1 to 5 uniformly; The mixed pharmaceutical excipients are mixed evenly with the active pharmaceutical ingredient, and then compressed in a tablet press to obtain tablets; Among them, the mass ratio of pharmaceutical excipients to pharmaceutical active ingredients is 2:

1.

7. The preparation method according to claim 6, characterized in that: The tabletting pressure is 10-20 kN, and the tabletting speed is 60-180 tablets / min.

8. The preparation method according to claim 6, characterized in that: The active ingredients of the medicine are tetracycline hydrochloride, oxytetracycline hydrochloride, aspirin or Scutellaria baicalensis leaves.

9. A tablet obtained by the preparation method according to any one of claims 5 to 7.

10. The tablet according to claim 6, characterized in that The disintegration time does not exceed 5s and the drug loading rate is not less than 85%.